FIELD: chemistry.
SUBSTANCE: invention relates to 3'-substituted spiro[3,9-dioxatetracyclo[5.3.2.02,4.08,10]dodec-5-en-11,2'-oxiranes] of formula (1) and spiro[3,9-dioxatetracyclo[5.3.2.02,4.08,10]dodec-5-en-12,2'-oxiranes of formula (2), where R = Ph, Hex. Invention also relates to a method for combined production of said compounds, which involves reacting bicyclo[4.2.2]deca-2,4,7-trienes with m-chloroperoxybenzoic acid at temperature of 0–40 °C, in dichloromethane for 3–23 hours
EFFECT: technical result is a method of producing novel compounds which can be used in medicine as biologically active substances having antitumour activity.
2 cl, 2 tbl, 3 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR COMBINED PRODUCTION OF ANTI-3,9,12-TRIOXAPENTACYCLO [5.3.3.0.0.0]TRIDEC-5-ENE, SYN-3,9,12-TRIOXAPENTACYCLO [5.3.3.0.0.0]TRIDEC-5-ENE AND 3,6,10-TRIOXAPENTACYCLO [6.3.2.0.0.0]TRIDEC-12-ENE EXHIBITING ANTITUMOUR ACTIVITY | 2019 |
|
RU2734346C1 |
METHOD OF PRODUCING 3,16,19-TRIOXAHEXACYCLO[10_5_3_0_0_0_0]ICOS-13-ENE EXHIBITING ANTITUMOUR ACTIVITY | 2019 |
|
RU2726355C1 |
METHOD FOR COMBINED PRODUCTION OF 1-METHYL-SUBSTITUTED BICYCLO[4_2_1]NONA-2,4,7-TRIENES EXHIBITING ANTITUMOUR ACTIVITY | 2019 |
|
RU2735663C1 |
METHOD OF PRODUCING (E)-BICYCLO[4,2,2]DECA-2,4,7-TRIENES | 2015 |
|
RU2605428C2 |
METHOD OF PRODUCING N-CONTAINING BICYCLO[4_2_1]NONA-2,4,7-TRIENES EXHIBITING ANTITUMOUR ACTIVITY | 2019 |
|
RU2735662C1 |
METHOD OF CO-PRODUCTION OF 1-ALKYL(PHENYL)BICYCLO[4.3.1]DECA-2,4,8-TRIEN-7,10-DIOLES AND 6-ALKYLBICYCLO[4.3.1]DECA-2,4,8-TRIEN-7,10-DIOLS | 2017 |
|
RU2677651C2 |
METHOD OF PRODUCING Si-CONTAINING BICYCLO[4,2,1]NONA-2,4,7-TRIENES | 2013 |
|
RU2559365C2 |
METHOD OF PRODUCING SI-CONTAINING BICYCLO[4_2_1]NONA-2,4,7-TRIENES EXHIBITING ANTITUMOUR ACTIVITY | 2018 |
|
RU2726195C2 |
AZACYCLIC SPIRO-COMPOUNDS | 2010 |
|
RU2550495C2 |
USE OF ETHYL 5-ARYL-4-OXO-2,2,6-TRIPHENYL-1-OXA-5-AZASPIRO[2.4]HEPT-6-ENE-7-CARBOXYLATES AS AGENTS WITH ANTIOXIDANT ACTIVITY | 2023 |
|
RU2813486C1 |
Authors
Dates
2020-11-05—Published
2019-04-24—Filed